The global Human Parenteral Nutrition market size is predicted to grow from US$ 8420 million in 2025 to US$ 13120 million in 2031; it is expected to grow at a CAGR of 7.7% from 2025 to 2031.

Parenteral nutrition is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to cure or prevent malnutrition. Human Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. Some people use parenteral nutrition to feed various vitamin or protein supplements through a tube placed into the stomach or small bowel.

The market for human parenteral nutrition has witnessed significant growth in recent years, driven by several factors. One of the primary drivers is the increasing prevalence of chronic diseases and medical conditions that require specialized nutrition support. Patients with conditions such as cancer, gastrointestinal disorders, malabsorption syndromes, or those undergoing major surgeries often require HPN to meet their nutritional needs.

Infinity Market Research newest research report, the Human Parenteral Nutrition Industry Forecast looks at past sales and reviews total world Human Parenteral Nutrition sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Parenteral Nutrition sales for 2025 through 2031. With Human Parenteral Nutrition sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Parenteral Nutrition industry.

This Insight Report provides a comprehensive analysis of the global Human Parenteral Nutrition landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Parenteral Nutrition portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Human Parenteral Nutrition market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Parenteral Nutrition and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Parenteral Nutrition.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Parenteral Nutrition market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Carbohydrate Nutrition
    Parenteral Lipid Emulsion Nutrition
    Single Dose Amino Acid Solution Nutrition
    Trace Element Nutrition
    Vitamins & Mineral Nutrition

Segmentation by Application:

    Hospital
    Clinic
    Nursing Home

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Baxter
    Allergan
    Actavis Inc.
    Otsuka Pharmaceutical Factory, Inc.
    Grifols, S.A.
    B. Braun Melsungen AG
    Vifor Pharma
    Fresenius Kabi AG
    Sichuan Kelun Pharmaceutical Co., Ltd.
    Pfizer Inc. (Hospira Inc.)
    Amanta Healthcare
    Aculife Healthcare
    Medipharm